Medicare Enrolled

Dr. Edward Karpman, MD

Urology Physician · Mountain View, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
2495 HOSPITAL DR STE 425, Mountain View, CA 94040
6509624662
In practice since 2006 (19 years)
NPI: 1851349609 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Karpman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Karpman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Karpman

Dr. Edward Karpman is an urology physician in Mountain View, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Karpman performed 179,285 Medicare services across 2,257 unique beneficiaries.

Between the years covered by Open Payments, Dr. Karpman received a total of $496,360 from 52 pharmaceutical and/or device companies across 847 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Karpman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in CA $496,360 industry payments

Medicare Practice Summary

Medicare Utilization ↗
179,285
Medicare services
Top 1% in CA for urology physician
2,257
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~9,436 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Testosterone undecanoate injection (Aveed)
An injection of testosterone undecanoate, a form of testosterone hormone. This procedure involves administering the medication via injection.
140,250 $1 $2
Testosterone injection
An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams.
34,600 $0 $0
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,179 $111 $239
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
864 $11 $51
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
651 $84 $140
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
366 $13 $57
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
256 $3 $30
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
238 $7 $196
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
199 $383 $751
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
124 $223 $512
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
111 $132 $363
Hormone pellet insertion under the skin
A small hormone pellet is placed just beneath the skin to release medication slowly over time.
110 $92 $250
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
59 $146 $357
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
52 $79 $200
Limited ultrasound of pelvis
A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment.
39 $46 $259
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
37 $115 $337
Ultrasound of penis artery and vein blood flow
An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins of the penis.
36 $118 $438
Insertion of multicomponent inflatable penile implant 32 $705 $1,886
Injection to cause erection
A procedure involving an injection administered to induce an erection.
24 $73 $219
Laser prostate fragmentation with bleeding control
This procedure uses a laser to break up prostate tissue and control bleeding through an endoscope.
20 $746 $2,265
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
14 $58 $506
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
13 $110 $556
Penile implant removal and replacement
Surgical removal of an existing inflatable penile implant and insertion of a new one during the same procedure.
11 $742 $2,016
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$496,360
Total received (2018-2024)
Avg $70,909/year across 7 years
Top 1% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
847
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$377,180 (76.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$89,037 (17.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,143 (6.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$21,212
2023
$29,272
2022
$65,452
2021
$79,800
2020
$44,335
2019
$152,054
2018
$104,236

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
COLOPLAST CORP
$18,017
Noah Medical Corporation
$1,000
Axonics, Inc.
$693
Antares Pharma, Inc.
$428
Endo Pharmaceuticals Inc.
$325
Medtronic, Inc.
$211
Sumitomo Pharma America, Inc.
$196
Astellas Pharma US Inc
$89
Innovation Technologies Inc
$84
Boston Scientific Corporation
$49
Endo USA, Inc.
$42
ABBVIE INC.
$39
PFIZER INC.
$21
PROGENICS PHARMACEUTICALS, INC.
$17
Top 3 companies account for 92.9% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$275,622
Coloplast Corp
$103,177
COLOPLAST CORP
$56,885
BOSTON SCIENTIFIC CORPORATION
$39,749
Innovation Technologies Inc
$7,156
Axonics, Inc.
$2,467
Endo Pharmaceuticals Inc.
$2,325
Antares Pharma, Inc.
$1,706
Noah Medical Corporation
$1,000
Astellas Pharma US Inc
$829
Sumitomo Pharma America, Inc.
$808
UROVANT SCIENCES INC
$602
PROCEPT BioRobotics Corporation
$415
Richard Wolf Medical Instruments Corp.
$350
Janssen Biotech, Inc.
$320
Supernus Pharmaceuticals, Inc.
$295
PFIZER INC.
$283
Medtronic, Inc.
$231
Dendreon Pharmaceuticals LLC
$225
ABBVIE INC.
$203
Amgen Inc.
$163
Agiliti Surgical, Inc.
$151
EDAP TECHNOMED INC
$125
Rigicon,Inc.
$107
MEDIVATION FIELD SOLUTIONS LLC
$97
Contura, Inc.
$83
Hollister Incorporated
$83
AbbVie, Inc.
$83
AbbVie Inc.
$76
Bayer HealthCare Pharmaceuticals Inc.
$60
Progenics Pharmaceuticals, Inc.
$59
180 Medical, Inc.
$58
Organogenesis Inc.
$43
Endo USA, Inc.
$42
Myriad Genetic Laboratories, Inc.
$42
Ferring Pharmaceuticals Inc.
$39
Rochester Medical Corporation
$38
BIOTISSUE HOLDINGS, INC.
$38
Teleflex LLC
$37
Photocure Inc
$31
UroGen Pharma, Inc.
$27
Laborie Medical Technologies Corp.
$25
TherapeuticsMD, Inc.
$24
Olympus America Inc.
$23
Tolmar, Inc.
$23
ACCORD HEALTHCARE, INC.
$23
AstraZeneca Pharmaceuticals LP
$23
C. R. Bard, Inc. & Subsidiaries
$20
PROGENICS PHARMACEUTICALS, INC.
$17
Allergan, Inc.
$16
Clarus Therapeutics Inc.
$16
SRS Medical Systems, Inc.
$15
Top 3 companies account for 87.8% of all-time payments
Associated products mentioned in payments ›
ADVANCE · AMS · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · AVEED · Altis · Androgel · AngioJet Ultra 5000A · AquaBeam Robotic System · Axonics · Axonics r-SNM System · BOTOX · Bulkamid · CAMCEVI · Coloplast TFL Drive · Cysview · EDEX · ELIGARD · ERLEADA · EVENITY · Erleada · FIRMAGON · GALAXY · GEMTESA · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · GENERAL ONCOLOGY · GENERAL THERAPIES · GENERAL UTERINE TISSUE REMOVAL · GENERAL - BPH · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · GENERAL KIDNEY STONE DISEASE · GENERAL MALE SUI · GENTLECATH · GREENLIGHT · Genesis · IMVEXXY · INTERSTIM · IRRISEPT · Infyna Chic · Irrisept · Isiris aStent Removal Device · JATENZO · JELMYTO · LUPRON DEPOT · LYNPARZA · Lupron · MAGIC3 · MYRBETRIQ · MYRISK · Myrbetriq · NEOX · NOCDURNA · Nubeqa · ORGOVYX · OTREXUP · Otrexup · PENILE & TESTICULAR RECONSTRUCTN · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · Prolia · Puraply · RIGI10 MALLEABLE PENILE PROSTHESIS · ROCHESTER MAGIC3 · SKYLITE · SPEEDICATH · Sonablate · SpeediCath · TESTOPEL · THERAPIES · TITAN · TLANDO · TOVIAZ · Titan · UROLIFT · UroCuff · VAPRO · VESICARE · VaPro · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for urology physician in CA.

Looking for an urology physician in Mountain View?
Compare urology physicians in the Mountain View area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
138
Per 100K population
7.3
County median income
$159,674
Nearest hospital
EL CAMINO HEALTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Karpman is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Karpman experienced with testosterone undecanoate injection (aveed)?
Based on Medicare claims data, Dr. Karpman performed 140,250 testosterone undecanoate injection (aveed) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Karpman receive payments from pharmaceutical companies?
Yes. Dr. Karpman received a total of $496,360 from 52 companies across 847 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Karpman's costs compare to other urology physicians in Mountain View?
Dr. Karpman's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Karpman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →